This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Hold American Tower (AMT) in Your Portfolio Now?
by Zacks Equity Research
Tower buyouts amid favorable trends in mobile-data usage are beneficial for American Tower (AMT). However, accelerated carrier consolidation-driven churn might hinder results.
The Zacks Analyst Blog Highlights: CBRE, Prologis, Duke Realty, First Industrial and EastGroup
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CBRE, Prologis, Duke Realty, First Industrial and EastGroup
Bet on These 4 Industrial REITs Despite No Rate Cut by Fed
by Moumita C. Chattopadhyay
REITs' business usually buoys up on a stepped-up economy and job scenario. With individual market dynamics playing key role in shaping returns, favorable conditions pump up chances of further growth.
Here's Why Momentum Investors Will Love EastGroup Properties (EGP)
by Zacks Equity Research
Does EastGroup Properties (EGP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Iron Mountain Enhances InSight's Offering With 2 Extensions
by Zacks Equity Research
Iron Mountain (IRM) adds sophisticated capabilities to Iron Mountain InSight for centralizing data access, and simplifying complex mortgage and loans processes.
Why Should You Bet on Crown Castle (CCI) Stock Right Now?
by Zacks Equity Research
Crown Castle (CCI) to witness solid carriers demand for 4G and future 5G deployment macro towers, backed by the company's efforts to boost its fiber footprint position.
Here's Why You Should Grab Cousins Properties (CUZ) Stock Now
by Zacks Equity Research
Cousins Properties (CUZ) strengthening its office platform, aided by acquisitions and new developments in Sun Belt markets, in a bid to benefit from favorable trends in the region.
Should You Hold Lamar (LAMR) Stock in Your Portfolio Now?
by Zacks Equity Research
Though Lamar Advertising (LAMR) has been banking on acquisitions and portfolio upgradation for growth, high capital expenditure related to these might impact free cash flow.
Welltower (Well) to Acquire 29 MOBs for $787M From Hammes
by Zacks Equity Research
Welltower (WELL) announces acquisition of 29 medical office buildings, bringing year-to date investment for its outpatient medical platform to $3.5 billion.
Welltower Announces JV With Invesco Real Estate Worth $850M
by Zacks Equity Research
Welltower (WELL) to raise $722.5 million in private capital by entering into a joint venture with Invesco Real Estate for a portfolio of 35 medical office buildings.